Neuronal Vulnerability in Parkinson Disease and Putative Therapeutics: Should the focus be on axonal and synaptic terminals?

While current effective therapies are available for the symptomatic control of Parkinsońs disease (PD), treatments to halt the progressive neurodegeneration still do not exist. Loss of dopamine neurons in the substantia nigra pars compacta and dopamine terminals in the striatum drive the motor featu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mov Disord
Autores principales: Wong, Yvette, Luk, Kelvin, Purtell, Kerry, Nanni, Samuel Burke, Stoessl, A. Jon, Trudeau, Louis-Eric, Yue, Zhenyu, Krainc, Dimitri, Oertel, Wolfgang, Obeso, Jose A., Volpicelli-Daley, Laura
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6879792/
https://ncbi.nlm.nih.gov/pubmed/31483900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27823
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares